| 1. |
Certain disclosure on page 1 of the Letter to Shareholders, page 1 of the Notice of Extraordinary General Meeting, and page 2 of the definitive proxy statement is hereby amended and restated to read as follows: |
Proposal No. 1 — The Extension Amendment Proposal — to amend, by way of special resolution, the Company’s amended and restated memorandum and articles of association (as amended, the “Articles”) as provided by the resolution in the form set forth on Annex A to the accompanying Proxy Statement (the “Extension Amendment” and, such proposal, the “Extension Amendment Proposal”) to (A) amend the date by which the Company must (1) consummate an initial merger, share exchange, asset acquisition, share purchase, reorganisation or similar business combination with one or more businesses (a “business combination”), (2) cease its operations except for the purpose of winding up if it fails to complete such business combination, and (3) redeem all of the ordinary shares of the Company, par value $0.0001 per share (the “ordinary shares”) included as part of the units sold in the Company’s initial public offering (such ordinary shares, the “Public Shares”) that was consummated on December 23, 2024 (the “IPO”), to up to 27 months from the closing of the IPO (the “Amended Date”), or such earlier date as is determined by our board of directors (the “board”), in its sole discretion, to be in the best interests of the Company (the “Amendment”), provided that Range Capital Acquisition Sponsor, LLC (the “Sponsor”) (or its affiliate or permitted designees) will deposit into a trust account established for the benefit of the Company’s public shareholders (the “Trust Account”) an amount determined by multiplying $0.03 by the number of public shares outstanding following any redemptions of public shares effected in connection with the Extraordinary General Meeting, up to a maximum of $60,000, for each such one-month extension, in exchange for a non-interest bearing, unsecured promissory note payable upon consummation of a business combination, and (B) reduce the liquidation and dissolution expenses that can be deducted from the interests earned on the funds held in the Trust Account from $100,000 to $20,000.
| 2. |
Certain disclosure on page 2 of the Letter to Shareholders, page 3 of the Notice of an Extraordinary General Meeting and page 18 of the definitive proxy statement is hereby amended and restated to read as follows: |
Based upon the amount in the Trust Account as of May 21, 2026, which was approximately $122,173,834.12, we anticipate that the per-share price at which Public Shares will be redeemed from cash held in the Trust Account will be approximately $10.62 at the time of the Extraordinary General Meeting (before deduction of taxes payable, if any). The closing price of the Public Shares on NASDAQ on May 21, 2026 the most recent practicable closing price prior to the mailing of this Proxy Statement, was $10.62. We cannot assure shareholders that they will be able to sell their shares in the open market, even if the market price per share is higher than the redemption price stated above, as there may not be sufficient liquidity in our securities when such shareholders wish to sell their shares.
| 3. |
Certain disclosure on page 1 of the Letter to Shareholders, and page 1 of the Notice of an Extraordinary General Meeting is hereby amended and restated to read as follows: |
The purpose of the Extension Amendment is to allow us more time to complete an initial business combination. The Articles currently provide that we have until June 23, 2026, the date that is 18 months from the consummation of our initial public offering, or such earlier date as may be determined by our board, to complete our initial business combination. Our board has determined that it is in the best interests of the Company to seek a modification of such language and have our shareholders approve the Extension Amendment Proposal to extend the date by which the Company must consummate a business transaction from 18 months to up to 27 months after the IPO (March 23, 2027), or such earlier date as may be determined by our board. provided that the Sponsor (or its affiliate or permitted designees) will deposit into the Trust Account an amount determined by multiplying $0.03 by the number of public shares outstanding following any redemptions of public shares effected in connection with the Extraordinary General Meeting, up to a maximum of $60,000, for each such one-month extension, in exchange for a non-interest bearing, unsecured promissory note payable upon consummation of a business combination. The Company will file a Current Report on Form 8-K within four business days following the date of each monthly contribution to the Trust Account.
| 4. |
Certain disclosure on page 2 of the definitive proxy statement is hereby amended and restated to read as follows: |
Like many blank check companies, our Articles provide for the return of the funds held in the Trust Account to our Public Shareholders if we do not consummate a business combination on or before a certain date (in our case, June 23, 2026). Our board has determined that it is in the best interests of the Company to amend the Articles to revise the date we have to consummate a business combination to up to 27 months from the closing of the IPO, or